Continuing Education for Healthcare Professionals
FCM Joint Providership Services
Within the framework of the ACCME requirements, there are opportunities for ACCME accredited providers like FCM to plan and implement CME activities with organizations that are not accredited by the ACCME. This approach refers to ‘joint providership’ and accounts for a sizable portion of the CME conducted annually by ACCME accredited providers.
FEATURED Online Courses
Reversal of Cognitive Decline: The Science, The Tools, and The Transformation
Presented by: Kenneth S. Sharlin, M.D., M.P.H., IFMCP Credits: 1.0 Learn More

This presentation will address the burden of Alzheimer’s disease in the United States and the role of amyloid beta in the progression of this disease. You will be given the tools to help prevent Alzheimer’s disease through lifestyle medicine and modification.

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

  1. Outline the burden of Alzheimer’s disease in the United States.
  2. Describe the role that the lipid-binding protein APoE4 plays in modifying the risk of Alzheimer’s disease.
  3. List at least two normal roles for amyloid beta in the brain.
  4. Describe the solutions lifestyle medicine provides to address the burden of Alzheimer’s disease.

To continue select your profession.

Diabetes Mellitus: Detecting and Treating Type 1 & 2 Patients In a Type 2 Global Epidemic
Presented by: Lorena Alarcon-Casas Wright, MD Credits: 1.0 Learn More

The program goal is to provide primary care providers with up-to-date knowledge and tools to correctly diagnose and differentiate patients with Type 1 vs Type 2 Diabetes and treat them appropriately for better patient outcomes.

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

  1. Identify the new glycemic goal targets for patients, and how best to achieve these goals
  2. Identify the most recent developments in therapeutics for Type II Diabetes (T2DM).
  3. Identify the less common Type I Diabetic in an epidemic of Type II.
  4. Apply the measures that can help prevent progression to T2DM in patients at risk.
  5. Implement the use of Toolkits to improve patient outcomes.

To continue select your profession.

Lateral Violence and Helping to Foster a Healthy Work Environment
Presented by: Ecoee Rooney, DNP, RN-BC, SANE-A Credits: 1.0 Learn More

The purpose of this course is to reflect on the current work environment, identify opportunities for improvements, and learn ways to promote a healthy workplace.

Participants will gain knowledge through improved communication, an environment that fosters inclusion and mutual support, and examine evidence-based practices that are within the control of the bedside nurse with the support of strong, caring nursing leadership.

Outcome Objectives
Upon completion of this learning activity, participants will:

  1. Report increased knowledge in techniques that improve work relationships to foster an improved working environment.
  2. Report their intent to change their practice to include techniques that improve interpersonal wellness and mutual support

To continue select your profession.

Clinical Diagnosis and Treatment for Complex Female HRT Patients
Presented by: Ilona Bleaman, PA-C, MHPE Credits: 1.0 Learn More

Women in their thirties well into their fifties commonly present to the office complaining of fatigue, weight gain, insomnia, irritability, acne, hair loss and decreased libido. Whether the patient is complaining of one or all of the above it is apparent that her quality of life is being affected. Many of these symptoms are frequently related to an imbalance or declining of their hormones.

Upon closer examination and analysis of patients’ prior lab work compared with current blood results it became apparent that often times only symptoms are being treated and not the underlying cause. For example, a 38 year old female with acne is commonly prescribed spironolactone yet the underlying origin or disease process, Polycystic Ovary Syndrome, is not identified or addressed. Additionally, perimenopausal women are often misdiagnosed and then prescribed inappropriate hormone regimens that result in an increase or new symptoms.

The intention of this webinar is to highlight and review a variety of cases with atypical patient presentations focusing on perimenopause and Polycystic Ovary Syndrome. The webinar identifies patients’ chief complaints and discusses their lab results. With this information an appropriate treatment plan is then developed. Practical clinical pearls are identified throughout the presentation.

To fully participate in this activity you must be Registered and Logged In to this website.

To continue select your profession.

Chronic Fatigue Syndrome and Hypothyroidism Are Linked To Low T3 Syndrome
Presented by: Neal Rouzier, MD Credits: 1.0 Learn More

Dr. Rouzier, will be reviewing Chronic Fatigue Syndrome and how the signs and symptoms are similar, to hypothyroidism. How many times these conditions are misdiagnosed and how to interpret your patient's medical condition to improve clinical outcomes.

Outcome Objectives:
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Review the work-up and diagnosis of Chronic Fatigue Syndrome.
  2. Recognize the many inflamed hormonal pathways in CFS.
  3. Discuss the pathophysiology involved in the development of CFS.
  4. Review thyroid lab tests as they pertain to CFS.
  5. Identify why it is called the hypometabolic syndrome.
  6. Review the studies that support normalizing TSH levels does NOT result in clinical euthyroidism.

To fully participate in this activity you must be Registered and Logged In to this website.

To continue select your profession.

Opioid Addiction: Challenging Cases in Diagnosis, Treatment, and Prevention
Presented by: Christine Mintz, MD Credits: 1.0 Learn More

It is estimated that each day more than 1000 people are treated in emergency departments for not using prescription opioids as prescribed. Combine this with illicit drug use and the cost of treatment and productivity losses related to addiction and we have a current epidemic costing Americans over 500 billion dollars and rising.

This interactive course will give the participant the resources and tools necessary to identify, educate and treat opioid tolerant and opioid addicted patients in primary care. We will cover the pathophysiology of opioids and their receptors, then we will transition to discussing tolerance vs. withdrawal and addiction. We will also review overdose antagonist medications, medication assisted treatments as well as briefly discuss new treatments and research on the horizon.

Outcome Objectives:
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the pathophysiology of opioid receptors in the dopamine reward pathway and how different opioids and opioid antagonists interact and bind to these receptors.
  2. Describe the common clinical features of chronic opioid abuse and suspected opioid withdrawal including appropriate diagnostic work-up.
  3. Discuss the current best practice treatment options for suspected opioid overdose including routes of administration and formulations as well as medication assisted treatment options.
  4. Identify new or emerging areas of research and treatment options for opioid dependence including pharmacologic and psychosocial strategies.

To fully participate in this activity you must be Registered and Logged In to this website.

To continue select your profession.

About FCM

Resource Downloads

Links